Scripps Memorial Hospital

The trials here

What the 15 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation7 trials
• Stroke4 trials
• Aortic stenosis2 trials
• Heart failure2 trials
• High blood pressure2 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Peripheral artery disease1 trial
• Pulmonary arterial hypertension1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting6 trials
• Completed6 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Boston Scientific Corporation9 trials
• Actelion1 trial
• Edwards Lifesciences1 trial
• Medtronic Cardiac Ablation Solutions1 trial
• Medtronic Cardiovascular1 trial
• and 2 more

Running trials

• Active, not recruiting

  Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)

  NCT07308847· Medtronic Cardiac Ablation Solutions· Source

• Recruiting

  Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  NCT07069738· Boston Scientific Corporation· Source

  Contact: Nicolas Olson, MD

• Recruiting

  AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

  NCT06959524· Boston Scientific Corporation· Source

  Contact: Matthew Price, MD

• Active, not recruiting

  SIMPLAAFY Clinical Trial

  NCT06521463· Boston Scientific Corporation· Source

• Active, not recruiting

  SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

  NCT05198674· Medtronic Vascular· Source

• Active, not recruiting

  SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

  NCT04722250· Medtronic Cardiovascular· Source

• Active, not recruiting

  CHAMPION-AF Clinical Trial

  NCT04394546· Boston Scientific Corporation· Source

• Active, not recruiting

  Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

  NCT04273945· Phase 3· Actelion· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting
• Heart failure1 recruiting

Closed trials

• Completed

  ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

  NCT06526546· Boston Scientific Corporation· Source

• Completed

  HEAL-LAA Clinical Trial

  NCT05809596· Boston Scientific Corporation· Source

• Completed

  Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

  NCT05007925· Shockwave Medical, Inc.· Source

• Completed

  LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

  NCT04790344· Boston Scientific Corporation· Source

• Completed

  Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

  NCT03795298· Boston Scientific Corporation· Source

• Terminated

  Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

  NCT02928497· Boston Scientific Corporation· Source

• Completed

  PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

  NCT01314313· Edwards Lifesciences· Source